background: Many hormone and ultrasound measurements have been assessed as possible markers of ovarian reserve and to identify potential poor responders to ovulation induction. The objective of this study is to determine whether multiple biomarkers measured in blood samples collected immediately before commencement of ovulation induction for IVF can predict the outcome of ovarian stimulation.
Introduction
The success of IVF and embryo transfer is dependent on an adequate response of the ovaries to exogenous gonadotrophin stimulation (Akande et al., 2002) . Treatment cancelation owing to poor ovarian response is a significant problem seen in 12-30% of all stimulated cycles (Keay et al., 1997) . Poor ovarian response to stimulation may be a consequence of advancing chronological age (Kim, 1995) although poor response may also occur unexpectedly in relatively young patients (Nikolaou and Templeton, 2003; Lambalk et al., 2009) . Although neuroendocrine and uterine factors may reduce fertility with age, progressive depletion of the size of the pool of ovarian follicles is thought to be the major cause of this problem. Decline in primordial follicle number with ageing has been linked to an equivalent decline in oocyte quality with adverse factors affecting both nucleus (aneuploidy, abnormal spindle formation) and cytoplasm (reduction in mitochondrial number and ATP, abnormalities of the cytoskeleton) (Ottolenghi et al., 2004) . Studies controlling for male causes of infertility by the use of donor sperm (Schwartz and Mayaux, 1982) or using donated oocytes from young donors to create embryos later transferred to the endometrial cavity of older recipients (Sauer, 1998) clearly show that age-related changes in oocytes are responsible for the majority of the decline in reproductive potential in women as they approach their fifth decade of life.
There are clear advantages to identifying women at risk of a poor response to ovulation induction before commencement of an IVF treatment cycle. IVF is expensive and invasive, and should not be performed if there is not a realistic chance of pregnancy. Although clinical experience suggests that most couples will go ahead with ovulation induction even if the likely response is poor, pretreatment identification of the 'poor responder' will allow directed counseling to be given, lessening the disappointment of cycle cancelation or poor oocyte yield and helping couples to decide to stop treatment earlier, avoiding multiple stimulation cycles. The availability of an accurate screening test of ovarian reserve would also allow those predicted to under-respond to be given higher doses of gonadotrophin without risk of ovarian hyperstimulation syndrome (OHSS), possibly improving oocyte yield (Arslan et al., 2005) .
Many hormonal and ultrasound measurements have been assessed as possible markers of ovarian reserve and to identify potential poor responders to ovulation induction (Johnson et al., 2006) although to date combinatorial methods have not been widely applied. Historically, combination of early follicular FSH and age was found to be better than age alone in predicting outcome in women undergoing IVF (Toner et al., 1991) . Many IVF centers continue to rely on early follicular phase measurement of FSH, notwithstanding limitations of month-by-month variation and disparity between assays. Inhibin B is released by granulosa cells of the developing ovarian follicle. Early follicular phase inhibin B correlates inversely with early follicular FSH level and has previously been used as an indicator of ovarian reserve (Seifer et al., 1999) . More recently, anti-Müllerian hormone (AMH) has Prediction of oocyte yield using multiple markers emerged as another marker with relevance to ovarian function. It is produced solely by the functional granulosa cells of growing pre-antral and small antral ovarian follicles (Weenen et al., 2004; Visser et al., 2006) , indirectly reflecting the size of the remaining primordial follicle pool and shows little inter-and intra-cycle variability (Hehenkamp et al., 2006; La Marca et al., 2007; Seifer and Maclaughlin, 2007; Tsepelidis et al., 2007) . Ultrasonographic measurements of antral follicle count (AFC) and ovarian volume have also been explored as predictors of response to ovulation induction. Whilst demonstrating good predictive ability and reliability in expert hands, problems of reproducibility limit their usefulness in practice .
The presence of such a wide range of tests of ovarian reserve suggests that no single test provides a sufficiently accurate result. A test based on a combination of markers might provide better identification of diminished ovarian reserve and act as a more sensitive predictor of response to ovarian stimulation in patients undergoing IVF treatment. Kline et al. (2005) produced predictive models based on chronological age, ovarian volume, FSH and inhibin B. Combinations of various markers (AFC, AMH and inhibin B) have also been used to predict poor response to stimulation, with up to 87% sensitivity, 80% specificity and a positive likelihood ratio of 4.36%. However, this scoring system was not tested for prediction of pregnancy (Muttukrishna et al., 2004 (Muttukrishna et al., , 2005 .
We have previously demonstrated the predictive ability for cycle cancelation of a number of endocrine markers measured in a group of women at high risk of poor response to ovulation induction (Mcllveen et al., 2007) . We now report the results of a large study on an unselected population of women entering IVF ovulation induction, powered to determine the ability of an ovarian reserve test (ORT) to predict the outcome of ovulation stimulation both in terms of oocyte yield and chance of pregnancy.
Materials and Methods

Study population
This prospective study included a total of 356 women undergoing IVF + ICSI at the Assisted Conception Units based at the Centre for Reproductive Medicine and Fertility, Jessop Wing, Sheffield and Hull IVF Unit. Informed consent was obtained from all women and the study was approved by the South Sheffield Research Ethics Committee. All women attending for IVF treatment during the study period (January 2008 -August 2009) were invited to participate, without exclusion because of previous treatments, female age, cause of infertility or other IVF related criteria. Routine practice in our unit is to restrict IVF treatment to patients with basal FSH , 13 IU/l. Therefore, there was an a priori selection bias against those with high FSH.
Of the 356 patients who agreed to participate, one withdrew before starting stimulation and three patients were canceled during stimulation for the following reasons: wrong timing of hCG (one), did not attend oocyte retrieval (one) and significant vaginal bleeding during stimulation (one Values are mean + SD, except for cause of infertility which are n (%). P-values are generated using Kruskal -Wallis test, except for cause of infertility (x 2 test) which is not reliable owing to small frequencies. AMH, anti-Müllerian hormone. represents those who proceeded to oocyte retrieval and had .4 oocytes (244 women). Out of 315 who had oocyte retrieval, 24 women did not proceed to embryo transfer. Seven of these women were from group 1B and 17 were from group 2B. One patient failed to have any oocytes collected and 10 women had complete failure of fertilization. Two women had elective cryopreservation of oocytes before chemotherapy. Embryo transfer was not performed in two patients because of identification of an endometrial irregularity during stimulation (possible polyp or thin endometrium), one woman had a suspected endometritis and eight women had elective cryopreservation of all embryos because of risk of OHSS (Fig. 1) .
Study protocol
All patients had blood collected on Day 2 of the menstrual cycle for measurement of FSH, LH, estradiol (E 2 ), inhibin B and AMH. A 4 ml blood sample was collected prior to the start of the IVF treatment cycle under investigation. Serum was stored at 2208C and analyzed later, all hormones being analyzed as a single batch. Each patient was given a unique numerical identifier which was used in data analysis to ensure anonymity of subjects. Transvaginal ultrasound was performed at the same visit using a 6-MHz probe (Toshiba, Sterling, UK). Controlled ovarian hyperstimulation was undertaken using protocols individualized according to patient age, previous response to gonadotrophins and basal FSH. Prescribing clinicians were not aware of the results of the assays for inhibin B or AMH. In most cycles (248 women, 69.9%) an antagonist protocol was used, with a mid-luteal phase start GnRH agonist long protocol being used for 15.5% of patients (55 women) and a early follicular phase start GnRH agonist 'flare' protocol for 52 (14.6%) of patients. Gonadotrophin dose was also prescribed on an individual basis according to multiple parameters including female age, Day 2 FSH, BMI and response in previous stimulation cycles. A minimum of 100 IU per day and a maximum of 450 IU per day were used. All patients received recombinant FSH without addition of LH. Dose adjustments were seldom made once the cycle had commenced.
A total of 10 000 IU of hCG were given when there were at least two leading follicles that measured ≥17 mm in the antagonist protocol and when there were at least two leading follicles that measured ≥18 mm in the GnRH agonist protocols (Devroey et al., 1994 (Devroey et al., , 2009 ). All follicles .12 mm were aspirated transvaginally under ultrasound guidance 34 -36 h after hCG. Oocyte number and quality were assessed by the embryologist. Fertilization was with IVF or ICSI according to cause of infertility. A maximum of two embryos were transferred on Day 3 following oocyte collection. An ongoing pregnancy was defined as the presence of fetal cardiac activity beyond 12 weeks gestation.
Cycle cancelation was recommended if less than three follicles of ≥14 mm mean diameter were seen when the lead follicle reached 18 mm (i.e. total mature follicle count ≤2). If a couple were advised to cancel the cycle, an intrauterine insemination was offered if appropriate (patent tubes and adequate sperm concentration and motility).
Cycle cancelation was also recommended for those with excessive response, with serum E 2 . 20 000 pMol/l and/or more than 20 follicles of ≥14 mm diameter on ultrasound.
Hormone assays
FSH and E 2 were measured using an automated multi-analysis system with chemoluminescence detection (Adiva Centaur; Bayer, Newbury, UK). For FSH, functional sensitivity was 0.3 IU/l, and intra-and inter-assay variabilities were ,3%. For E 2 , functional sensitivity was 26 pmol/l, and intra-and inter-assay variabilities were ,11 and 7%, respectively. Inhibin B concentrations were measured in duplicate using a specific two-site enzymelinked immunosorbent assay (ELISA) kit (Oxford Bio-Innovation Ltd, Oxford, UK) according to the manufacturer's protocol. The assay detection limit for inhibin B was ,5 pg/ml. Within-plate and between-plate coefficient of variation (CV) were 6 and 8%, respectively. Serum AMH samples were assayed in duplicate using the AMH/MIS ELISA kit (Immunotech-Beckman, Marseilles, France) according to the manufacturer's protocol. The detection limit of the assay was ,3 pmol/ml (0.42 ng/ml). Each sample was analyzed in duplicate. A standard curve was established using AMH standards that were provided in the kit, and the intra-assay CV was 12.3% and the inter-assay CV was 14.2%.
Statistical analysis
Power calculation
A sample size calculation was performed using the end-point of prediction of ongoing pregnancy using logistic regression modeling. Assuming that the blood test score will be normally distributed, the odds of ongoing pregnancy at the mean blood test score is estimated to be one-third and the odds ratio following a 1 SD reduction in blood test score from the mean is estimated to be p 2 ¼ 1.414. Using a 5% significance level, this leads to a requirement of 348 participants for 80% power.
Statistical methods
We performed all statistical analyses using STATA (SE 8.2, StataCorp, College Station, TX, USA). Quantitative variables are presented as mean + SD and qualitative variables as number (%). Normality was evaluated with the Kolmogorov-Smirnov test. Due to the non-normality of quantitative variables, Mann-Whitney test was used to compare two independent groups and Kruskal-Wallis test to compare more than two groups. The association of cause of infertility with different groups was assessed using Fisher's exact test. Spearman correlation was used to assess the association between two quantitative variables. The univariate logistic regression analyses were used to estimate the risk of each independent variable on the dependent variable and multivariate logistic regression analyses were used to assess the independent effect of these variables after controlling confounding between them. The area under the receiver operating characteristic curve (ROC AUC ) was computed to assess the predictive accuracy of each independent variable and the logistic regression model. We created an ORT value from multivariate logistic regression equation in which age, FSH, inhibin B and AMH were considered as predictors for poor response and negative pregnancy. A P-value of ,0.05 was considered as statistically significant.
Results
Baseline, treatment and outcome characteristics
Baseline, treatment and outcome characteristics of the study population are summarized in Table I . Three hundred and fifty-six women were eligible for this study (Fig. 1) . Twenty-eight (7.9%) treatment cycles were canceled for a poor ovarian response (Group 1A). Nine (2.5%) treatment cycles were canceled for excessive response (Group 2A). Three hundred and fifteen women underwent oocyte retrieval (315/355: 88.7%). Those who underwent oocyte retrieval were divided into two groups: Group 1B (71/352 women; 20.2%) including those with oocyte yield of ≤4 and Group 2B (244/352 women; 69.3%) including those with oocyte yield of .4. There were significant differences between different groups in terms of age, duration of stimulation, peak E 2 level as well as FSH, inhibin B and AMH but not in the cause of infertility (Table I) . Table II compared Group 1 (1A and 1B) with Group 2 (2A and 2B). Patients in Group 1 were older, having lower concentrations of inhibin B and AMH and higher FSH concentrations compared with those in Group 2. Group 2 had significantly higher number of embryos as well as a higher ongoing pregnancy rate compared with Group 1.
Twenty-six women (Group 2A who were canceled prior to oocyte retrieval because of an excessive response and 17 women who were had their embryos frozen for different reasons) were excluded from the pregnancy analysis. Group 1A were included in the pregnancy analysis as their poor response was the reason for their cancelation. Comparison between those with ongoing pregnancy (88, 27%) and those without (238, 73%) revealed that there were significant differences in age (P ¼ 0.002), AMH (P ¼ 0.038) and total amount of recombinant FSH used (P ¼ 0.008) between the two groups (Table II) . Women with ongoing pregnancy were younger, had higher AMH and received lower amounts of recombinant FSH. There were borderline significant differences in number of oocytes and number of embryos between the two groups (P ¼ 0.056 and P ¼ 0.055, respectively). No significant differences were observed in concentrations of FSH or inhibin B, duration of stimulation or peak E 2 level. Prediction of oocyte yield using multiple markers Table III shows that there were significant correlations between different variables (age, FSH, inhibin B and AMH) for number of oocytes as well as number of embryos. The correlation between AMH and number of oocytes was the strongest (r s ¼ 0.502).
The results of the logistic regression analyses for the prediction of poor response (≤4 oocytes) are given in Table IV . Univariate analyses showed that age, FSH, inhibin B and AMH were significant predictors for poor oocyte yield. AMH presented the highest ROC AUC of 0.827, indicating a good discriminating potential for predicting poor ovarian response, followed by FSH with an ROC AUC of 0.721. In the multivariate analysis, the variables age, FSH and AMH remained significant and the resulting model provided a high ROC AUC of 0.819. ROC curve analysis facilitates the selection of cutoff values that maximize sensitivity, specificity and accuracy (Fig. 2) . The ovarian reserve log model ROC curve for poor responders estimated that an ORT value of 0.30 produced a maximized sensitivity of 76.8% and a specificity of 76.6%. (Table V) . The results of univariate and multivariate logistic regression analyses showed that age was the only significant predictor for negative pregnancy outcome with an ROC AUC of 0.610 (Table IV) . None of the individual markers of ovarian reserve were able to predict pregnancy. However, adding these endocrine markers to the pregnancy log model will increase ROC by only 0.023. The pregnancy log model ROC curve for negative pregnancy outcome estimated that a value of 0.73 produced a maximized sensitivity of 62.5% and a specificity of 61.4% (Table V) . Women with an ORT of ,0.3 have more than a 75% chance of having their treatment cycle canceled, but a value over 0.73 indicates a 38% chance of pregnancy. Figure 3 shows the relationship between the log model values for no pregnancy and 
Discussion
This prospective study demonstrated that a derived multi-marker computation for measuring ORT was a good predictor for oocyte yield after ovulation induction and also for ongoing pregnancy. The analysis showed that the ability of the derived ORT to predict pregnancy was related to the inclusion of age in the ORT formula. The ability of the test to predict pregnancy was relatively modest, which is unsurprising given the large number of other variables that impact on chances of ongoing pregnancy after IVF and which are external to ovarian reserve. These include the effects of sperm quality, endometrial receptivity and other uterine factors. Both endocrine and ultrasound methods of assessing ovarian reserve appear to measure the quantity of follicles in the developing cohort rather than oocyte 'quality' . In a subfertile population, the ideal test would accurately predict oocyte quality as well as oocyte yield, with better ability to determine the likelihood of pregnancy and live birth. ORT had the ability to predict chance of ongoing pregnancy.
The ability of the computed ORT to predict pregnancy outcome is further enhanced by inclusion of the oocyte yield per unit FSH dose, as shown in Fig. 3 . This computation takes into account the finding that pregnancy is less likely in those women who have poor oocyte yield notwithstanding treatment with high doses of FSH, representing the most gonadotrophin-resistant group of 'poor responders'. Several hormonal markers and ultrasound parameters have been used to estimate ovarian reserve and predict those with a poor chance of success in assisted reproduction techniques: these include age, FSH, LH, E 2 , inhibin B, AMH, ovarian volume and ovarian AFC. Others have advocated the use of dynamic tests using ovarian response to GnRH, FSH or clomiphene citrate to assess ovarian function (Coccia and Rizzello, 2008 This is mainly a result of the inclusion of female age in the ORT formula. This model could be used clinically for testing of ovarian reserve and prediction of oocyte yield. Further refinement is needed before chance of pregnancy can be better predicted with sufficient accuracy for clinical use, probably with inclusion of novel determinants of oocyte quality, sperm function and endometrial receptivity. It will also be of interest to study the summative chance of pregnancy once the patients included in the study have completed transfer of their frozen embryos. These data will take several years to accrue but it seems likely that the ability of the ORT to predict pregnancy will improve since those who score highest in the test have the greatest chance of having frozen embryos for use later. Not all women will respond normally to ovulation induction. Use of biochemical markers measured before commencement of stimulation has been shown to identify those at high risk of poor response (Mcllveen et al., 2007) , findings confirmed in the deliberately heterogeneous group of patients assessed in our study. Forewarning of poor response will reduce the stress caused by cycle cancelation or low oocyte yield and may help the couple to move on to other more appropriate treatments for their infertility and avoid the cost and futility of repeated stimulation cycles. Equally, pretreatment assessment of ovarian reserve can be used to identify patients at risk of ovarian hyperstimulation (Nelson et al., 2009) . Such patients require treatment with low doses of FSH in a GnRH antagonist controlled cycle, with careful monitoring and a low threshold for cycle cancelation or cryopreservation of all embryos without fresh transfer (Mathur et al., 2007) . Moreover, the use of GnRH agonist for triggering the final oocyte maturation in a GnRH antagonist controlled cycle is now a valid preventive measure for highrisk patients (Humaidan et al., 2010) .
An accelerated depletion of primordial follicles appears to occur around the age of 38 years (Fady and Gosden, 1995) . The onset of the effects of diminished ovarian reserve on fertility varies from individual to individual and can be detected at a younger age in some women (Scott and Hofmann, 1995) . The accelerated diminution of ovarian reserve is reflected by a rise in serum concentration of FSH and reduced concentrations of AMH. Young women with poor ovarian response to ovulation induction during IVF treatment are at risk of early menopause (Nikolaou et al., 2002) confirming that ovarian response to ovulation induction can be used as a surrogate marker for overall ovarian reserve.
Hence, we can use the number of oocytes recovered after ovulation induction as a surrogate marker for natural ovarian reserve. Further research to test the ability of ORT to identify individuals with a diminished (or possibly also enhanced) ovarian reserve in the general, noninfertile population is needed, although these studies will of necessity be very long-term. In recent years, the tendency to postpone childbearing (Astolfi et al., 1999) has resulted in more and more Western women trying to have children at a more advanced age, with increased likelihood of 'unexplained' infertility (Van Zonneveld et al., 2001) . Screening for 'early ovarian aging' in the late 20s or early 30s using ORT could provide information to women to allow them to make rational decisions about their fertility, allowing those with a smaller than average follicle pool to consider early attempts to conceive, or perhaps to decide to cryopreserve oocytes or embryos for use later.
